RESUMO
To investigate seroprevalence of anti-Leptospira antibodies in equines and associated workers in Uruguay, 891 equine and 150 human sera were drawn; 212 equine urine samples were also taken for culture. Environmental conditions and equine raising or managing practices were recorded in all 72 visited establishments; epidemiological information was obtained from each worker. Microscopic agglutination technique (MAT) was performed with 10 Leptospira strains for equines and 18 for human sera, that were also studied with IgM indirect immunofluorescence (IgM-IIF). Equine titres ≥100 were considered positive, and human sera titres ≥200 suggested probable recent or past infection. Urines were cultured in Ellinghausen-McCullough-Johnson-Harris (EMJH) media; local identification of one obtained isolate with lipL32 PCR, Multiple Locus Variable number tandem repeat Analysis and partial rrs gene sequencing, were completed at Institut Pasteur, Paris. Estimated reactivity was 61.3% for equines, which was higher than the studied bovine national levels (21%) and mainly observed with Icterohaemorrhagiae serogroup (40.3%), Sejroe, Canicola, Pomona or Ballum. Aged animals from slaughterhouses and cattle farms were the most frequently positive. Multiple regression analysis confirmed a significant association between seropositivity and equine age. Only one positive culture could be fully studied, and confirmed to be Leptospira interrogans serogroup Canicola; it was added to the MAT antigen panel and revealed fairly frequent reaction with equine and human sera. Three workers (2%) showed titres = 200 with Icterohaemorrhagiae or Canicola serogroups, without recent clinical manifestations. Their attended equines reacted with the same serogroups, suggesting common source infections or infection transmitted by equines. Three other humans yielded titres = 100, and none of the 150 showed an IgM-IIF-positive result. Equines seem not to be an important origin of regional human leptospirosis, except perhaps during acute animal infection. More culture work is required to study intensity and lapses of leptospiruria, as well as to further identify circulating strains.
Assuntos
Doenças dos Bovinos , Doenças dos Cavalos , Leptospira interrogans , Leptospira , Leptospirose , Animais , Anticorpos Antibacterianos , Bovinos , Doenças dos Cavalos/epidemiologia , Cavalos , Imunoglobulina M , Leptospirose/epidemiologia , Leptospirose/veterinária , Estudos Soroepidemiológicos , SorogrupoRESUMO
OBJECTIVE: To assess the incremental cost-utility ratio (ICUR) of gemtuzumab ozogamicin (GO) + standard of care (SOC) vs SOC alone for treatment of patients with de novo AML from a Spanish Health Service perspective. METHODS: A cohort state-transition model, with 12 health-states, was used to estimate the lifetime accumulated cost and benefits in terms of quality-adjusted-life-years (QALYs) in AML patients with favourable, intermediate, and unknown cytogenetic profiles. Patient profile was defined based on the ALFA-0701 trial. Therapeutic regimens were defined by 5 haematologists. SOC was assumed to be idarubicin and cytarabine, the combination most used in Spain. QALYs were estimated by applying utilities for the time spent by the cohort in each health-state and utility decrements associated with adverse events (AE). Total cost (,2020) included drug-acquisition, hematologic stem-cell transplantation, disease management, AE management and end-of-life costs. Unit costs were derived from local databases. All parameters were validated by haematologist. Costs and outcomes were discounted (3%/year). RESULTS: Higher cost/patient (177,618 vs 151,434) and greater QALYs (5,70 vs 4,62) were obtained with GO+SOC vs SOC. The ICUR was 24,203/QALY gained. CONCLUSION: This simulation suggests that GO + SOC could be a cost-effective option for treatment of patients with de novo AML in first line.
RESUMO
Drought stress in plants causes differential expression of numerous genes. One of these differentially expressed genes in rice is a specific amidohydrolase. We characterized this amidohydrolase gene on the rice chromosome 12 as the first plant guanine deaminase (OsGDA1). The biochemical activity of GDA is known from tea and coffee plants where its catalytic product, xanthine, is the precursor for theine and caffeine. However, no plant gene that is coding for GDA is known so far. Recombinant OsGDA1 converted guanine to xanthine in vitro. Measurement of guanine and xanthine contents in the OsGDA1 knockout (KO) line and in the wild type Tainung 67 rice plants also suggested GDA activity in vivo. The content of cellular xanthine is important because of its catabolic products allantoin, ureides, and urea which play roles in water and nitrogen stress tolerance among others. The identification of OsGDA1 fills a critical gap in the S-adenosyl-methionine (SAM) to xanthine pathway. SAM is converted to S-adenosyl-homocysteine (SAH) and finally to xanthine. SAH is a potent inhibitor of DNA methyltransferases, the reduction of which leads to increased DNA methylation and gene silencing in Arabidopsis. We report that the OsGDA1 KO line exhibited a decrease in SAM, SAH and adenosine and an increase in rice genome methylation. The OsGDA1 protein phylogeny combined with mutational protein destabilization analysis suggested artificial selection for null mutants, which could affect genome methylation as in the KO line. Limited information on genes that may affect epigenetics indirectly requires deeper insights into such a role and effect of purine catabolism and related genetic networks.
Assuntos
Guanina Desaminase , Oryza , Amidoidrolases/genética , Amidoidrolases/metabolismo , Secas , Epigenoma , Regulação da Expressão Gênica de Plantas , Oryza/genética , Oryza/metabolismoRESUMO
INTRODUCCIÓN: La incidencia de la enfermedad meningocócica invasiva (EMI) por serogrupo C ha disminuido desde la introducción de la vacunación sistemática el año 2000. El objetivo de este estudio es determinar los casos de EMI diagnosticados desde entonces y los fallos vacunales en los casos por serogrupo C. PACIENTES Y MÉTODOS: Análisis retrospectivo de pacientes diagnosticados de EMI confirmada por cultivo o reacción en cadena de la polimerasa, en un hospital infantil de tercer nivel de Barcelona, entre 2001 y 2018. Se analizó el número de dosis de vacuna recibidas y la edad, recogidos de la historia clínica y del carnet de vacunaciones. RESULTADOS: Se confirmaron 128 casos de EMI (7,1 casos/año; 70,3% en < 5 años). Se estudió el serogrupo en 125 casos (97,6%): 103 fueron B (82,4%), 10 fueron C (8%), uno fue 29E (0,8%) y uno fue Y (0,8%); solo 10 (8%) no fueron serogrupables. De los 10 pacientes con serogrupo C, 4 no estaban vacunados y en 3 la pauta fue incompleta en cuanto a número de dosis; 3 de ellos recibieron la pauta completa según la edad y el calendario vacunal vigente, por lo que se consideran fallos vacunales. Fallecieron 6 pacientes (tasa de letalidad: 4,7%): 5 por serogrupo B (letalidad: 4,8%) y uno por serogrupo C (letalidad: 10%). CONCLUSIONES: El serogrupo C representó solo el 8% de los casos de EMI en el periodo de estudio y los fallos vacunales de este serogrupo fueron del 30%
INTRODUCTION: The incidence of serogroup C invasive meningococcal disease (IMD) has decreased since the introduction of systematic vaccination in 2000. The aim of this study is to determine the number of serogroup C IMD cases diagnosed since then and the vaccine failures. PATIENTS AND METHODS: A retrospective analysis was performed on patients diagnosed with IMD by culture or polymerase chain reaction (PCR) in a maternity and childhood hospital in Barcelona between 2001 and 2018. An analysis was made of the number of vaccine doses and the age received, as well as on the medical records and vaccine cards. RESULTS: There were 128 confirmed cases of IMD (7.1 cases/year; 70.3 in < 5 years). The serogroup was studied in 125 (97.6%) cases, in which 103 (82.4%) were B, 10 (8%) were C, one (0.8%) was 29E, and one (0.8%) was Y, and only 10 (8%) were not able to be serogrouped. Of the 10 patients with serogroup C, 4 were not vaccinated, and in 3, the course was not complete as regards the number of doses. The other 3 received the complete course according to age and current calendar, and thus were considered vaccine failures. A total of 6 patients died (mortality rate: 4.7%), 5 due to serogroup B (mortality: 4.8%), and one due to serogroup C (mortality: 10%). CONCLUSIONS: Serogroup C only represented 8% of IMD cases in the period studied, with 30% of cases due to this serogroup being vaccine failures
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Infecções Meningocócicas/diagnóstico , Infecções Meningocócicas/epidemiologia , Neisseria meningitidis Sorogrupo B/imunologia , Neisseria meningitidis Sorogrupo C/imunologia , Vacinas Conjugadas/imunologia , Vacinas Meningocócicas/imunologia , Estudos Retrospectivos , Infecções Meningocócicas/microbiologia , Programas de Imunização/métodosRESUMO
INTRODUCTION: The incidence of serogroup C invasive meningococcal disease (IMD) has decreased since the introduction of systematic vaccination in 2000. The aim of this study is to determine the number of serogroup C IMD cases diagnosed since then and the vaccine failures. PATIENTS AND METHODS: A retrospective analysis was performed on patients diagnosed with IMD by culture or polymerase chain reaction (PCR) in a maternity and childhood hospital in Barcelona between 2001 and 2018. An analysis was made of the number of vaccine doses and the age received, as well as on the medical records and vaccine cards. RESULTS: There were 128 confirmed cases of IMD (7.1 cases/year; 70.3 in <5 years). The serogroup was studied in 125 (97.6%) cases, in which 103 (82.4%) were B, 10 (8%) were C, one (0.8%) was 29E, and one (0.8%) was Y, and only 10 (8%) were not able to be serogrouped. Of the 10 patients with serogroup C, 4 were not vaccinated, and in 3, the course was not complete as regards the number of doses. The other 3 received the complete course according to age and current calendar, and thus were considered vaccine failures. A total of 6 patients died (mortality rate: 4.7%), 5 due to serogroup B (mortality: 4.8%), and one due to serogroup C (mortality: 10%). CONCLUSIONS: Serogroup C only represented 8% of IMD cases in the period studied, with 30% of cases due to this serogroup being vaccine failures.
Assuntos
Infecções Meningocócicas , Vacinas Meningocócicas , Neisseria meningitidis Sorogrupo C , Criança , Humanos , Infecções Meningocócicas/epidemiologia , Infecções Meningocócicas/mortalidade , Estudos Retrospectivos , Sorogrupo , Espanha/epidemiologiaRESUMO
INTRODUCCIÓ: Una causa infreqüent al nostre entorn d'hipertensió arterial pulmonar (HAP) és l'esquistosomiasi, una parasitosi causada per Schistosoma mansoni I Schistosoma haematobium. És habitual en pacients d'àrees endèmiques, que en alguns casos poden desenvolupar HAP. CAS CLÍNIC: Presentem el cas d'un pacient de 13 anys, originari de Mali, que consulta per dolor toràcic I símptomes vegetatius associats a l'exercici. En l'exploració física destaquen un segon to cardíac augmentat I esplenomegàlia. Es troba en insuficiència cardíaca classe II de la NYHA. L'ecocardiografia mostra dilatació I hipertròfia ventricular dretes, amb signes indirectes d'hipertensió pulmonar, que es confirma per cateterisme. Tenint en compte la procedència del pacient, s'amplia l'estudi etiològic amb la investigació de la presència de Schistosoma en orina I femta, que resulta positiu per S. mansoni I S. haematobium. S'inicia tractament amb praziquantel I sildenafil; la parasitosi es resol I milloren els símptomes. COMENTARIS: La simptomatologia de l'esquistosomiasi varia segons les característiques de la infecció, la durada I la càrrega parasitària. La definició d'HAP associada a esquistosomiasi es basa en la confirmació mitjançant cateterisme juntament amb la presència del paràsit en orina o femta, I l'evidència d'afectació hepatoesplènica mitjançant ecografia. La patogènesi és encara desconeguda I el tractament no està ben establert, de manera que l'estratègia terapèutica és igual a la de l'HAP idiopàtica. Els antiparasitaris no han demostrat que poden canviar el pronòstic. La seva elevada morbiditat en població jove fa que hi hagi interès a millorar el control de l'HAP associada a esquistosomiasi
INTRODUCCIÓN: Una causa infrecuente en nuestro medio de hipertensión arterial pulmonar (HAP) es la esquistosomiasis, una parasitosis causada por Schistosoma mansoni y Schistosoma haematobium. Es habitual en pacientes de áreas endémicas, pudiendo desarrollar en algunos casos HAP. CASO CLÍNICO: Presentamos el caso de un paciente de 13 años, originario de Mali, que consulta por dolor torácico y síntomas vegetativos asociados al ejercicio. En la exploración física destacan un segundo tono cardiaco aumentado y esplenomegalia. Se encuentra en insuficiencia cardiaca clase II de la NYHA. La ecocardiografía muestra dilatación e hipertrofia ventricular derechas, con signos indirectos de hipertensión pulmonar, que se confirma por cateterismo. Dada la procedencia del paciente, se amplía el estudio etiológico investigando la presencia de Schistosoma en orina y heces, que resulta positivo para S. mansoni y S. haematobium. Se inicia tratamiento con prazicuantel y sildenafilo; la parasitosis se resuelve y mejoran los síntomas. COMENTARIOS: La sintomatología de la esquistosomiasis varía según las características de la infección, la duración de la misma y la carga parasitaria. La definición de HAP asociada a esquistosomiasis se basa en la confirmación de ésta mediante cateterismo junto con la presencia del parásito en orina o heces, y la evidencia de afectación hepatoesplénica mediante ecografía. Su patogénesis es aún desconocida y el tratamiento no está bien establecido, y la estrategia terapéutica es igual a la de la HAP idiopática. Los antiparasitarios no han demostrado cambiar el pronóstico. Su elevada morbilidad en población joven hace que haya interés en mejorar el control de la HAP asociada a esquistosomiasis
INTRODUCTION: Schistosomiasis, a parasitosis caused by Schistosoma mansoni and Schistosoma haematobium may cause pulmonary arterial hypertension (PAH). While common in endemic areas, schistosomiasis is an uncommon cause of PAH in our environment. CASE REPORT: We present the case of a 13-year-old male, originally from Mali, who consulted for chest pain and vegetative symptoms associated with exercise. Physical examination revealed an increased second heart tone and splenomegaly, consistent with NYHA class II heart failure. Echocardiography showed dilatation and right ventricular hypertrophy, with indirect signs of pulmonary hypertension, which was confirmed by catheterization. Given the origin of the patient, diagnostic studies were expanded to investigate the presence of Schistosoma spp. in urine and feces, which resulted positive for S. mansoni and S. haematobium. Treatment with praziquantel and sildenafil was started, resulting in resolution of the parasitosis and improvement of the symptoms. COMMENTS: The symptoms of schistosomiasis may vary depending on the characteristics of the infection, the duration of the disease and the parasitic load. The definition of PAH associated with schistosomiasis is based on the confirmation of PAH by catheterization along with the presence of the parasite in urine or feces, and the evidence of hepatosplenic involvement by ultrasound. Its pathogenesis is still unknown and the treatment is not well established, although same principles of management of idiopathic PAH are recommended. Antiparasitic drugs have not shown to impact prognosis. Its high morbidity in young population justify the interest in improving the control of PAH associated with schistosomiasis
Assuntos
Humanos , Masculino , Pré-Escolar , Hipertensão Pulmonar/diagnóstico por imagem , Hipertensão Pulmonar/parasitologia , Esquistossomose mansoni/complicações , Esquistossomose Urinária/complicações , Esquistossomose Urinária/diagnóstico por imagem , Schistosoma haematobium/isolamento & purificação , Schistosoma mansoni/isolamento & purificaçãoRESUMO
Leptospirosis is important in Uruguay due to the economic loss caused by the diseases of production animals, mainly bovines, and also due to frequent human infection. We decided to study anti-Leptospira antibodies in the sera of dairy workers, rice laborers, veterinarians, suburban slum dwellers and garbage recyclers. Our aims were to estimate the seroprevalence of infection by Leptospira spp. in these people at risk, the relative importance of the known risk factors associated with infection, and the impact of human infections in each setting. Groups at risk were identified and 35 visits to their locations were made, conducting field surveys and exchange talks for information and education. Simple epidemiological questionnaires were administered and sera samples were taken from 308 persons. The microagglutination Technique (MAT) and the IgM Indirect Immunofluorescence (IIF) assay were employed to detect antibodies. Environmental water samples, canine and equine sera were also examined. More than 45% of human sera were reactive and the studied groups were confirmed to be widely exposed to infection. Female sera were frequently reactive, though most illnesses occur in men, and the most severe cases in elderly males; the emergence and evolution of the disease may strongly depend on the host condition and functions. Animal contact and unsafe water usage were the main identified risk factors to be considered in prevention. Fifty per cent of the studied horses showed a positive MAT reaction. The underdiagnosis of the illness and its long-term symptoms require further study, as well as greater health and social attention efforts.
Assuntos
Anticorpos Antibacterianos/sangue , Leptospira/imunologia , Leptospirose/sangue , Leptospirose/epidemiologia , Adolescente , Adulto , Idoso , Exposição Ambiental/efeitos adversos , Feminino , Humanos , Leptospirose/etiologia , Masculino , Pessoa de Meia-Idade , Exposição Ocupacional/efeitos adversos , Fatores de Risco , Estudos Soroepidemiológicos , Condições Sociais , Uruguai/epidemiologia , Adulto JovemRESUMO
Immune checkpoint inhibitors are currently tested in different combinations in patients with advanced hepatocellular carcinoma (HCC). Nivolumab, an anti-PD-1 agent, has gained approval in the second-line setting in the USA. Epigenetic drugs have immune-mediated antitumor effects that may improve the activity of immunotherapy agents. Our aim was to study the therapeutic efficacy of checkpoint inhibitors (anti-CTLA-4 and anti-PD-1 antibodies) in combination with the histone deacetylase inhibitor (HDACi) Belinostat. In a subcutaneous Hepa129 murine HCC model, we demonstrated that Belinostat improves the antitumor activity of anti-CTLA-4 but not of anti-PD-1 therapy. This effect correlated with enhanced IFN-γ production by antitumor T-cells and a decrease in regulatory T-cells. Moreover, the combination induced early upregulation of PD-L1 on tumor antigen-presenting cells and late expression of PD-1 on tumor-infiltrating effector T-cells, suggesting the suitability of PD-1 blockade. Indeed, Belinostat combined with the simultaneous blockade of CTLA-4 and PD-1 led to complete tumor rejection. These results provide a rationale for testing Belinostat in combination with checkpoint inhibitors to enhance their therapeutic activity in patients with HCC.
Assuntos
Antígeno CTLA-4/antagonistas & inibidores , Carcinoma Hepatocelular/tratamento farmacológico , Inibidores de Histona Desacetilases/administração & dosagem , Ácidos Hidroxâmicos/administração & dosagem , Neoplasias Hepáticas Experimentais/tratamento farmacológico , Receptor de Morte Celular Programada 1/antagonistas & inibidores , Sulfonamidas/administração & dosagem , Animais , Linhagem Celular Tumoral , Modelos Animais de Doenças , Quimioterapia Combinada , Feminino , Humanos , Macrófagos/fisiologia , Camundongos , Camundongos Endogâmicos C3H , Linfócitos T Reguladores/imunologiaRESUMO
Tumor infiltrating lymphocytes have been associated with a better prognostic and with higher response rates in patients treated with checkpoint inhibiting antibodies, suggesting that strategies promoting tumor inflammation may enhance the efficacy of these currently available therapies. Our aim was thus to develop a new vaccination platform based on cold-inducible RNA binding protein (CIRP), an endogenous TLR4 ligand generated during inflammatory processes, and characterize whether it was amenable to combination with checkpoint inhibitors. In vitro, CIRP induced dendritic cell activation, migration and enhanced presentation of CIRP-bound antigens to T-cells. Accordingly, antigen conjugation to CIRP conferred immunogenicity, dependent on immunostimulatory and antigen-targeting capacities of CIRP. When applied in a therapeutic setting, vaccination led to CD8-dependent tumor rejection in several tumor models. Moreover, immunogenicity of this vaccination platform was enhanced not only by combination with additional adjuvants, but also with antibodies blocking PD-1/PD-L1, CTLA-4 and IL-10, immunosuppressive molecules usually present in the tumor environment and also induced by the vaccine. Therefore, priming with a CIRP-based vaccine combined with immune checkpoint-inhibiting antibodies rejected established B16-OVA tumors. Finally, equivalent activation and T-cell stimulatory effects were observed when using CIRP in vitro with human cells, suggesting that CIRP-based vaccination strategies could be a valuable clinical tool to include in combinatorial immunotherapeutic strategies in cancer patients.
RESUMO
Epigenetic alterations are increasingly implicated in the initiation and progression of cancer. Genome-wide (global) hypomethylation seems to occur in early neoplasia and is a feature of genomic DNA derived from solid tumour tissues like ovarian cancer. Thus, analytical methods that provide sensitive and quantitative information about cytosine methylation in DNA are currently required. In this work, we compare two different anion-exchange columns for the separation of methylated cytosine from the other DNA nucleotides: a silica-based (Tracer Extrasil SAX) column and a polystyrene/divinyl benzene-based (Mono-Q™) column. Under the optimised conditions, linearity range, precision and detection limits of the developed high-performance liquid chromatography (HPLC) method were evaluated and compared using conventional ultraviolet (UV) absorbance detection at 270 nm. Good separation of the five target nucleotides, including 5-methyl-2'-deoxycytidine monophosphate (5mdCMP) and 2'-deoxycytidine monophosphate (dCMP) was achieved on the Mono-Q™ column with a gradient elution of ammonium acetate buffer (1 M, pH 6.9) at a flow rate of 1 mL min(-1). The coupling of this column to inductively coupled plasma mass spectrometry (ICP-MS) permitted also phosphorous ((31)P) specific detection of the nucleotides. Both detection systems offered adequate analytical performance characteristics, with detection limits of 30 and 40 µg L(-1) for 5mdCMP by HPLC-UV and HPLC-ICP-MS, respectively. However, the latter method allowed the determination of the global DNA methylation level (%) without the need for external calibration. Different genomic DNA samples were analysed including calf thymus DNA and DNA from two human cancer cell lines (adenocarcinoma epithelial A549 and ovarian carcinoma A2780) using the proposed strategy. In the line A2780, the cisplatin-sensitive and cisplatin-resistant variants were analysed, finding no significant differences in the methylation percentage after treatment with cisplatin.
Assuntos
Antineoplásicos/farmacologia , Cromatografia por Troca Iônica/métodos , Cisplatino/farmacologia , Desoxicitidina/análogos & derivados , Neoplasias Ovarianas/genética , Resinas de Troca Aniônica/química , Linhagem Celular Tumoral , Cromatografia por Troca Iônica/instrumentação , Metilação de DNA , Desoxicitidina/química , Desoxicitidina/genética , Desoxicitidina/metabolismo , Feminino , Humanos , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/metabolismoRESUMO
Human mesenchymal stromal/stem cells (MSC) isolated from fetal tissues hold promise for use in tissue engineering applications and cell-based therapies, but their collection is restricted ethically and technically. In contrast, the placenta is a potential source of readily-obtainable stem cells throughout pregnancy. In fetal tissues, early gestational stem cells are known to have advantageous characteristics over neonatal and adult stem cells. Accordingly, we investigated whether early fetal placental chorionic stem cells (e-CSC) were physiologically superior to their late gestation fetal chorionic counterparts (l-CSC). We showed that e-CSC shared a common phenotype with l-CSC, differentiating down the osteogenic, adipogenic and neurogenic pathways, and containing a subset of cells endogenously expressing NANOG, SOX2, c-MYC, and KLF4, as well as an array of genes expressed in pluripotent stem cells and primordial germ cells, including CD24, NANOG, SSEA4, SSEA3, TRA-1-60, TRA-1-81, STELLA, FRAGILIS, NANOS3, DAZL and SSEA1. However, we showed that e-CSC have characteristics of an earlier state of stemness compared to l-CSC, such as smaller size, faster kinetics, uniquely expressing OCT4A variant 1 and showing higher levels of expression of NANOG, SOX2, c-MYC and KLF4 than l-CSC. Furthermore e-CSC, but not l-CSC, formed embryoid bodies containing cells from the three germ layer lineages. Finally, we showed that e-CSC demonstrate higher tissue repair in vivo; when transplanted in the osteogenesis imperfecta mice, e-CSC, but not l-CSC increased bone quality and plasticity; and when applied to a skin wound, e-CSC, but not l-CSC, accelerated healing compared to controls. Our results provide insight into the ontogeny of the stemness phenotype during fetal development and suggest that the more primitive characteristics of early compared to late gestation fetal chorionic stem cells may be translationally advantageous.
Assuntos
Córion/citologia , Células-Tronco Fetais/citologia , Células-Tronco Mesenquimais/citologia , Placenta/citologia , Antígenos Embrionários Estágio-Específicos/metabolismo , Adulto , Animais , Biomarcadores/metabolismo , Diferenciação Celular , Córion/metabolismo , Feminino , Células-Tronco Fetais/metabolismo , Células-Tronco Fetais/transplante , Humanos , Fator 4 Semelhante a Kruppel , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Transgênicos , Placenta/metabolismo , Células-Tronco Pluripotentes/citologia , Células-Tronco Pluripotentes/metabolismo , Gravidez , Primeiro Trimestre da Gravidez , Terceiro Trimestre da Gravidez , Pele/lesões , Antígenos Embrionários Estágio-Específicos/genética , Transplante de Células-Tronco , Fatores de Tempo , Transplante Heterólogo , CicatrizaçãoRESUMO
Introducción: la infección por Estreptococo grupo B (EGB) puede afectar gravemente a la madre y al feto durante la gestación y al recién nacido luego del parto. Actualmente, eldiagnóstico de colonización durante el embarazo se realiza por métodos microbiológicos a partir de exudados vaginorrectales. Objetivo: desarrollar métodos rápidos y de bajo costo para la detección del antígeno grupo específico de EGB en exudados vaginorrectales.Material y método: se utilizaron dos cepas de EGB, una autóctona (IH23) y la cepa de referencia O90R, que solo expresa el polisacárido específico de grupo. Para cada una se preparó un antisuero policlonal que se utilizó para el desarrollo de un test inmunocromatográfico y uno de aglutinación de látex. Como controles se emplearon cultivos bacterianos, polisacáridos purificados de EGB y muestras vaginorrectales. Resultados: los límites de detección obtenidos para la inmunocromatografía fueron de 210 μg/ml y 50 μg/ml para los polisacáridos purificados de sobrenadante y pared, respectivamente, no lográndose detectar antígenos de EGB en las muestras clínicas analizadas. El límite dedetección del látex fue 65 μg/ml frente al polisacárido purificado de sobrenadante de cultivo de IH23 y 6,5 x 107 UFC/ml de IH23. La sensibilidad y especificidad para el látex fue de 30% y90%, respectivamente. Conclusiones: los métodos desarrollados no alcanzaron el límite de detección requerido parasu aplicación en muestras clínicas. Esto concuerda con lo descripto en la bibliografía para ensayos rápidos basados en reacciones antígeno-anticuerpo y muestra la necesidad deagregar pasos previos de extracción y concentración o mejorar la calidad de los reactivos inmunológicos empleados.
Introduction: group B streptococcal infection (GBS) may seriously affect mother and fetuses during pregnancy, and the newborn after delivery. Today, diagnosis of colonization during pregnancy is done by means of microbiological methods of vaginal and rectal exudates. Objective: to develop fast and low cost methods to detect the GBS specific group antigen in vaginal-rectal exudates. Method: we used two EGB strains, one of the (IH23)autochthonous and the reference strain O90R, that only expresses the group specific polysaccharide. We prepareda polyclonal antiserum for each one of them which was used to conduct an immunochromatographic test and alatex agglutination test. We used bacterial culture, EGB purified polysaccharides and vagina,-rectal samples as control. Results: detection limits obtained for the immunochromatographic test were 210 μg/ml and 50 μg/ml for purifiedpolysaccharides and cell wall, respectively, there being no EGB antigens detected in the clinical samples analyzed. Latex detection limit was 65 μg/ml compared to purified polysaccharides of IH23 culture supernatant and 6,5 x 107 UFC/ml of IH23. Sensitivity and specificity for latex was 30% and 90% respectively.Conclusions: the methods used failed to reach the detection limit required for its application in our clinical samples. This agrees with what is described in bibliography about quick tests based on antigen-antibody reactions and indicated the need to add previous extractionand concentration steps or to improve the quality of the immunologic reagents used.
Introdução: a infecção por Estreptococo grupo B (EGB) pode afetar gravemente a mãe e o feto durante a gravidez e o recém nascido imediatamente depois do parto. Atualmente, o diagnóstico de colonização durante a gestação é feita por métodos microbiológicos empregando exsudados vaginorretais.Objetivo: desenvolver métodos rápidos de baixo custo para a detecção do antígeno grupo específico de EGB emexsudados vaginorretais. Material e método: foram utilizadas duas cepas deEGB, uma autóctone (IH23) e a cepa de referência O90R, que expressa somente o polissacarídeo específico do grupo.Para cada uma foi preparado um antisoro policlonal utilizado para o desenvolvimento de um teste imunocromatográfico e um de aglutinação de látex. Foram empregadoscultivos bacterianos, polissacarídeos purificados de EGB e amostras vaginorretais como controles. Resultados: os limites de detecção obtidos para a imunocromatografia foram de 210 μg/ml e 50 μg/ml para ospolissacarídeos purificados de sobrenadante e parede, respectivamente, no sendo possível detectar antígenos de EGB nas amostras clínicas analisadas. O limite dedetecção do látex foi 65 μg/ml quando comparado com o polissacarídeo purificado de sobrenadante de cultivo deIH23 y 6,5 x 107 UFC/ml de IH23. A sensibilidade e especificidade para o látex foi de 30% y 90%, respectivamente. Conclusões: os métodos desenvolvidos não alcançaramo limite de detecção requerido para sua aplicação em amostras clínicas. Estes resultados são similares aos dadosdescritos na bibliografia para ensaios rápidos baseados em reações antígeno-anticorpo e mostram a necessidade de agregar passos prévios de extração econcentração ou melhorar a qualidade dos reativos imunológicos utilizados.